Moreover, CEA is sensitive to cancer recurrence, thus, it is often used to determine the efficacy of cancer therapy, monitor the disease progression and prognosis, etc. Many efforts have been made to develop new technologies to improve the sensitivity for cancer biomarker analysis3, 4, 5. This evidence concerns the gene CEACAM5 and cancer.